Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Endometrial adenocarcinoma
ADR ID BADD_A01486
ADR Hierarchy
21      Reproductive system and breast disorders
21.07      Uterine, pelvic and broad ligament disorders
21.07.02      Uterine neoplasms
21.07.02.011      Endometrial adenocarcinoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.12      Reproductive neoplasms female malignant and unspecified
16.12.02      Endometrial neoplasms malignant
16.12.02.003      Endometrial adenocarcinoma
Description An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues. [MeSH]
MedDRA Code 10014720
MeSH ID D018269
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Adenocarcinoma endometrial | Adenocarcinoma endometrial metastatic | Adenocarcinoma endometrial recurrent | Adenocarcinoma endometrial stage 0 | Adenocarcinoma endometrial stage I | Adenocarcinoma endometrial stage II | Adenocarcinoma endometrial stage III | Adenocarcinoma endometrial stage IV | Endometrial adenocarcinoma | Endometrial adenocarcinoma metastatic | Endometrial adenocarcinoma recurrent | Endometrial adenocarcinoma stage 0 | Endometrial adenocarcinoma stage I | Endometrial adenocarcinoma stage II | Endometrial adenocarcinoma stage III | Endometrial adenocarcinoma stage IV | Endometrioid adenocarcinoma | Endometrioid adenocarcinoma metastatic | Endometrioid adenocarcinoma recurrent | Endometrioid adenocarcinoma stage 0 | Endometrioid adenocarcinoma stage I | Endometrioid adenocarcinoma stage II | Endometrioid adenocarcinoma stage III | Endometrioid adenocarcinoma stage IV | Endometrioid carcinoma | Carcinoma, Endometrioid | Carcinomas, Endometrioid | Endometrioid Carcinoma | Endometrioid Carcinomas | Adenocarcinoma, Endometrioid | Adenocarcinomas, Endometrioid | Endometrioid Adenocarcinomas | Endometrioid Adenocarcinoma
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00861Exemestane0.001046%
BADD_D01253Lenalidomide0.000482%
BADD_D01257Letrozole0.000580%
BADD_D01281Levonorgestrel0.004728%
BADD_D01418Methotrexate0.000114%
BADD_D01913Ranitidine--
BADD_D02112Tamoxifen citrate--
BADD_D02250Toremifene citrate0.000334%
BADD_D02464Fingolimod0.000603%
The 1th Page    1    Total 1 Pages